Background
==========

The well documented needs of an ageing population have lead to an increased demand for research examining the determinants and conditions that promote healthy ageing \[[@B1],[@B2]\]. Longitudinal studies have been identified as an important source of information on the ageing process through their unique ability to track a variety of events and conditions and the interactions between them over an extended period of time \[[@B3]\]. A large number of cohort studies now exist, both in Australia and abroad (see \[[@B4]\] for review), that to a varying extent have sought to address issues associated with the ageing process.

Despite this, there still remain few comprehensive studies investigating the biomedical physical, psychological, social and behavioural elements of the ageing process in Australian men, in spite of poorer health outcomes when compared to ageing women \[[@B5]\]. Compared to women, Australian men have higher rates of physical and psychological disease, and death. Generally, men are also less likely than women to adopt a healthier lifestyle \[[@B6]\]. Despite these disparities, the health of men and changes in their health status with ageing is one of the most understudied areas of health research. This has lead to a number of peak and government bodies to call for a comprehensive men\'s health longitudinal study \[[@B7]-[@B9]\]. Accordingly, a well-characterised cohort of men representing a range of age groups, and followed for an extended period, is considered of value.

The Florey Adelaide Male Ageing Study (FAMAS) is a multi-disciplinary population cohort study examining the health and health-related behaviours of men, aged 35--80 years and living in the north-west regions of Adelaide. It employs a broad range of investigative procedures in assessing the variable interactions that contribute to the health and health related behaviours of men. The principal aims of FAMAS are to investigate: 1) Incidence of and risk factors associated with chronic physical and psychological disorders in a representative group of Australian men; 2) Endocrinology of the ageing male and its relationship with age, health status and male-specific conditions (e.g. prostate health, erectile function, lower urinary tract symptoms); 3) Determinants of the utilization of health services amongst males. The main outcome variables are incidence of chronic health conditions (e.g. diabetes, cardiovascular disease, asthma, musculoskeletal conditions, cancer, obesity); sexual health and function; prostate health and function (including lower urinary tract symptoms); muscle strength and function; psychological disorders and function, male health service utilization, general health and well-being; physical activity levels; medication usage. In addition, the project involves a number of cross-sectional sub-studies investigating specific age related conditions.

This paper details the study methodology of FAMAS, including the design, sample techniques and clinic and research protocols used. To date there is little data on the factors associated with participation in the few longitudinal studies that specifically investigate the health of men in Australia. Research from other ageing cohort studies suggest that time constraints, low socio-economic status, smoking status and a lack of perceived benefit are all significant barriers to participation in men \[[@B10]-[@B12]\]. This is an area requiring further investigation in the Australian male population. Potential sources of selection and observational bias will be also examined through analysis of sampling and attrition. Finally, the cohort will be compared with available national data on key demographics for comparability with the target populations.

Methods
=======

Study design
------------

The Florey Adelaide Male Ageing Study (FAMAS) is a population-based longitudinal study that commenced in 2002 involving 1195 men aged 35--80 years recruited from the north-west regions of Adelaide. As a result of funding availability men were enrolled in two phases: from August 2002 until July 2003, inclusive (Phase 1, 568 participants) and June 2004 to May 2005 (Phase 2, 627 participants). Participants are asked to complete annual follow-up questionnaires tracking any changes to their contact, health status and health service utilization. In addition, other issues such as gambling activities, sleep structure, personal relationships and personal stressors are explored. Subjects are also invited to participate in additional nested case-control studies with selected collaborators. Follow-up full clinic evaluations are scheduled to occur at five-yearly intervals.

### Ethics & participant feedback

All protocols herein were approved by the Royal Adelaide Hospital Research Ethics committee and, where appropriate, the Aboriginal Health Research Ethics Committee of South Australia.

Participants were provided with feedback upon completion of all study procedures. Following baseline clinics, a copy of all relevant results (laboratory, clinical) accompanied with an explanatory cover letter was sent to participants\' and, where permission was given, to their nominated physician. In the case of a clinically significant result, participants were advised to immediately contact their treating physician for further examination.

Participant recruitment
-----------------------

### Participant criteria & sampling

Participants in the study were required to be male, aged between 35 and 80 years at the time of recruitment, living in the defined catchment area of north and west Adelaide with a connected telephone and number listed in the Electronic White Pages (EWP), be willing and able to comply with the protocol and give written, informed consent. Exclusion criteria were limited to living outside the catchment area and telephone numbers that belonged to non-residential properties (i.e. businesses, institutions and residential-care facilities) in accordance with the desire to accurately reflect the male population of the sample. Highly trained recruitment staff were also instructed to exclude respondents if they were: a) of insufficient mental or physical ability to understand the requirements of participation or adequately participate; b) to ill or otherwise incapacitated to attend clinics; c) currently residing in an institution (e.g. aged care facility); or d) had severely limited English (see also: *Recruitment & CATI survey*).

The sample was stratified into the two health regions directly under investigation: Western Adelaide and Northern Adelaide. The northern and western areas of Adelaide comprise approximately half of the city\'s population and over a third of the State\'s population. These regions broadly reflect the demographic profile of the State\'s population.

Residential households were selected at random, with the male person aged between 35 and 80 years to last have his birthday invited for interview and study participation. This method of randomly selecting within the household avoids a selection bias towards the unemployed, retired or homemakers \[[@B10],[@B12]\].

### Recruitment & CATI survey

In accordance with established mailing protocols \[[@B13]\], a letter introducing the study, along with an information brochure, was sent to selected households approximately 2 weeks prior to attempting to contact the residence. The letter and brochure informed potential participants of the purpose of the study and indicated that they could expect to be contacted by telephone. Contact details were also supplied for willing participants who for logistical reasons, could not be contacted during regular recruitment period hours. A number of initiatives were undertaken to increase general awareness of the study in the target community. These included local media events (television, print and radio) and a study launch held at a national sporting complex and opened by the State\'s health minister, with various political, sporting and business identities and members of the general public attending.

The telephone recruitment was conducted by an external agency with qualified staff utilizing a Computer-Assisted Telephone Interviewing (CATI) system. This method utilises the Electronic White Pages (EWP) as the sampling frame, using six digits of the standard eight digit telephone number in addition to prefixes and exchanges provided by the directory\'s administrator (Telstra) within geographically defined areas. This technique yields a final sampling frame that is more than adequate to cover all households within the catchment areas and has been demonstrated to be as effective as other survey methods \[[@B14]\]. The CATI transcript included a series of questions relating to the interviewees demographics (age group, residential location, predominant occupation, number of adults/children in household), history of health conditions/events (physician nominated diabetes, asthma, bronchitis, emphysema, heart attack, stroke, angina or none) and nominated risk factors (smoking, weight/height self-estimates, hypercholesterolemia, hypertension). The transcript also allowed the coding of all reasons for non-participation (i.e. poor to no English skills, too busy, lack of perceived benefit, too old, don\'t want to, too sick, none given or other).

Following removal of all non-residential telephone numbers from the drawn sample, calls were made on alternate evenings and weekends to maximize chance of contact. Calls were also made on other occasions if specifically requested. In general, no more than ten attempts were made to the same phone number. Upon contacting the household, the interviewer firstly identified themselves and the purpose of the study. The interviews were conducted in English however every attempt was made to be as inclusive as possible for all interviewees. When required for poor-English speaking interviewees, a friend or family member of the interviewee was arranged to join the telephone interview as an interpreter (and attend the subsequent clinic session). To further facilitate recruitment, the interview was restricted to approximately 15 minutes duration. Participants were subsequently given reminder calls on the eve of their clinic visit. The period between screening call and clinic was generally within a fortnight and no more than two months

Measurements
------------

### Clinic visits

Baseline visits took place at the Queen Elizabeth (TQEH) and Lyell McEwin Health Service (LMHS) depending on a participants residence. In general, clinics were held from Monday to Saturday (between 0700 and 1130) on alternating weeks at the respective locations. Participants arrived following an overnight fast of approximately 12 hours for a blood draw. If a subject\'s medication regimen prevented a fasting visit, this was duly recorded in the clinic notes.

Prior to participation, subjects were sent a clinic pack containing all study documentation (information & consent forms, personal, secondary & physician contact detail forms) as well as the self-administered FAMAS Questionnaire A. This was compiled as a general health and wellbeing questionnaire with well-validated measures extensively used in population research. Questionnaire A included standard demographic questions based on those in the Australian Census 2001 \[[@B15]\] regarding ethnicity, income, education and work status, and health information regarding medical conditions, prior surgery, medication use and cigarette smoking from other statutory sources \[[@B16]\]. Also included in this questionnaire was the 36-item short-form health survey (SF-36, \[[@B17]\]), the Beck Depression Inventory (BDI, \[[@B18]\]), physical activity measure (1999 National Physical Activity Survey, \[[@B19]\]), the International Prostate Symptom Scale (IPSS, \[[@B20]\]) and items assessing symptoms of obstructive sleep apnoea (OSA, \[[@B21]\]). Clinic packs also included the Australian Cancer Council of Victoria\'s (ACCV) self-administered, optically scanned Food Frequency Questionnaire (FFQ), used to assess the composition of participants\' diets \[[@B22]\].

During clinic visits, a separate questionnaire assessing sexual desire and erectile function (Questionnaire B) was completed in private. This included the Sexual Desire Inventory 2 (SDI-2, \[[@B23]\]), the International Index of Erectile Function (IIEF, \[[@B24]\]) and a Global Impotence Rating (GIR, \[[@B25]\]). Participants were also required to complete a brief survey recording their levels of engagement with a variety of health care providers and satisfaction with available services (Health Service Utilization Questionnaire; see Additional File [1](#S1){ref-type="supplementary-material"}).

Anthropometry (height, weight, waist and hip measurements as per Norton & Olds \[[@B26]\]), blood pressure measurements, a brief neuropsychological assessment (Fuld Object Memory Evaluation \[[@B27]\], Trail Making Test \[[@B28]\] and finger tapping & handgrip strength \[[@B29]\]), and uroflowometry tests were also completed during the approximate 45-minute clinic visit (see below). In addition, clinic staff had the capacity to record any other observations on participants deemed to be of clinical relevance.

### Blood sample

A fasting blood sample (approximately 25 ml) was taken upon arrival at clinic by venipuncture in the antecubital fussa and immediately refrigerated and transported to a NATA certified laboratory for analysis. Measured and calculated parameters are summarized in Table [1](#T1){ref-type="table"}. Surplus serum was stored at -70°C for future analysis. An additional 5 ml of whole blood was collected for DNA analysis.

###### 

Laboratory measurements

  Laboratory Measurement                                                                     Analytic Method
  ------------------------------------------------------------------------------------------ -------------------------------
   **Androgens/Steroids**                                                                    
  Total Testosterone (TT)                                                                    Immulite 2000
  Bioavailable Testosterone (BT)                                                             as per O\'Connor et al., 1973
  Sex Hormone Binding Globulin (SHBG)                                                        Immulite 2000
  Insulin-like Growth Factor (IGF-1; IGF-BP3)                                                
                                                                                             
   **Lipids**                                                                                
  Total Cholesterol                                                                          Olympus AU5400
  High Density Lipoprotein Cholesterol (HDL)                                                 Olympus AU5400
  Low Density Lipoprotein Cholesterol (LDL)                                                  Olympus AU5400
  Total Triglycerides                                                                        Olympus AU5400
                                                                                             
   **Glucose**                                                                               
  Glucose                                                                                    Olympus AU5400
  Haemoglobin A1c (HbA1c)                                                                    Biorad Variant II
  Insulin                                                                                    Abott Axsym
                                                                                             
   **Prostate**                                                                              
  Prostate Specific Antigen (PSA)                                                            Abott ARCHITECT^©^
                                                                                             
   **Reproductive**                                                                          
  Follicle Stimulating Hormone (FSH)                                                         Abott ARCHITECT^©^
  Luteinizing Hormone (LH)                                                                   Abott ARCHITECT^©^
  Oestradiol (E~2~)                                                                          Immulite 1
                                                                                             
   **Thyroid**                                                                               
  Thyroid Stimulating Hormone (TSH)                                                          Abott ARCHITECT^©^
  Triiodothyronine (T~3~)                                                                    Abott ARCHITECT^©^
  Thyroxine (T~4~)                                                                           Abott ARCHITECT^©^
                                                                                             
   **Liver**                                                                                 
  Liver Function Test (including: Bilirubin, GGT, ALP ALP, ALT, AST, LD)                     Olympus AU5400
                                                                                             
   **Kidney**                                                                                
  Urea                                                                                       Olympus AU5400
  Creatinine                                                                                 Olympus AU5400
  Urate                                                                                      Olympus AU5400
  Phosphate                                                                                  Olympus AU5400
                                                                                             
   **Blood**                                                                                 
  Complete Blood Exam (including: Haemoglobin, Haemodynamics, Platelets, White Cell Count)   Sysmex 1000i
  Electrolytes (Sodium, Potassium, Chloride, Bicarbonate)                                    Olympus AU5400
  Protein (including: Albumin, Globulin)                                                     Olympus AU5400
  Calcium (Total & calculated Ionized)                                                       Olympus AU5400

Immulite 1 & Immulite 2000:Diagnostic Products Corporation, Los Angeles, Ca.;

Abbott Axsym & Abbott Architect: Abbott Diagnostics, Abbott Park Illinois; Olympus AU5400: Olympus Optical, Shizuoka-ken, Japan; Biorad Variant II: Biorad, Hercules, Ca.; Sysmex 1000i: Sysmex, Kobe, Japan.

### Uroflowometry

A portable uroflowometry analyser (UROCAP-II, Laborie Medical, Technologies, Ontario, Canada) was used to measure multiple characteristics of a participant\'s urine flow (peak & mean flow; voiding & flow time; time to peak flow; voided volume). Following completion of testing, a small sample (approximately 5 ml) was collected and stored for later analysis.

### DEXA scans

Participants had whole body and lumbar spine bone mineral density (BMD) and whole body and regional body fat and lean mass measured by dual energy x-ray absorptiometry (DEXA) at their earliest convenience using the LUNAR DPX+ pencil beam densitometer (GE Lunar Corporation). Participants were informed of radiation exposure levels (\~0.18 μSv per scan) and given the opportunity to discuss the procedure with an experienced administrator. Ultimately, 89.5% of participants agreed to a DEXA scan, with work commitments being the major reason cited for non-attendance.

### HIC data

Following specific consent from participants, data were obtained from Medicare Australia on participants\' usage of the Medicare & Pharmaceutical Benefits Schemes and linked with self reports of health conditions, health service and medication usage. This data is anticipated to be collected at every clinic wave.

### Follow-up questionnaires (FUQ)

Study participants are also required to complete annual questionnaires documenting any changes to their contact and physician details as well including repeated measures on health and physical status. In addition to repeated measures, stable variables (e.g. birth weight) are regularly included in questionnaires to better characterize the cohort. FUQ\'s are expected to take no more than 15 minutes to complete. FUQ\'s are mailed to participants at the end of the week corresponding to their initial clinic visit. After a two-week period all participants with outstanding questionnaires are contacted by phone and asked to complete the questionnaire over the phone. If contact cannot be made, or if the participant does not have time, attempts are made to make contact the participant the following week for up to six weeks (assuming the participant remains willing). If after this period contact cannot be made, participant details are sought through all available secondary contacts (including nominated physicians) until notification is received. All contact with participants is logged into the study database.

### Sub studies

In addition to the primary research aims of FAMAS, a number of sub studies have commenced in collaboration with researchers from various fields. The sub-studies are run in parallel with the main study. For a particular sub-study, the enrolment criteria are defined, potential participants identified from the database, and a letter is sent with an invitation to enrol, with a follow-up telephone call after one week. Projects were required to be broadly related to the aims of FAMAS, to be either of informative or health value to participants and to avoid excessive contact. These have been detailed previously \[[@B30]\].

Cohort retention strategies
---------------------------

Several previously successful strategies in maximizing cohort retention and maintaining regular contact were adopted. These included study branding for ease of recognition in the general and research community, explaining longitudinal nature of research, using experienced and friendly staff during clinics, placing emphasis on the potential direct and indirect health benefits to participants and the broader community, detailed contact information whilst emphasising confidentiality measures, use of reply paid envelopes for all source documentation and refunding postage fees incurred by participants \[[@B13],[@B31]\]. Other measures adopted to maintain regular participant contact and ascertain current status included: i) *Birthday & Christmas Cards*(also served to improve participant compliance); ii) *Biannual Newsletter*(an additional avenue to disseminate study results and general information); iii) *Follow-up Questionnaires*(a primary data source that includes participants\' personal, secondary and health provider details).

A strict series of guidelines were also adopted for participant withdrawal and deaths. In the case of death, mortality data is also monitored from statutory sources (e.g. S.A Births, Death & Marriages Registration Offices, S.A. Cancer Registry, & National Death Index).

Representativeness
------------------

The representativeness of the cohort was assessed through comparison of selected demographic data (age, region, marital status, educational data, income & work status) with the 2001 Census figures \[[@B15]\] for the target (northern & western Adelaide) and Australian population.

Data collection & analyses
--------------------------

All study data collected is checked for completeness and clarity upon receipt and stored on a secure SQL server, backed up nightly and accessed through a customized management information system. All source and linked data undergo random quality control checks for corruptions during data migration.

For responders vs. non-responders, and active participants vs. withdrawn, groups were compared using chi-square tests and the resulting standardized cell residuals for categorical characteristics and t-tests for continuous characteristics, where appropriate.

Results
=======

Response rates
--------------

Figure [1](#F1){ref-type="fig"} shows the participant disposition from initial random sampling through to participation in study clinics. After adjusting for those not contactable or ineligible in accordance with the methods of Slattery et al \[[@B32]\], the response rate for the study (percentage of sample eligible for recruitment) was 67.8%, the overall participation rate (percentage of eligible sample who agreed to be interviewed) was 70.7% and the final response rate of the eligible sample that ultimately attended the clinic was 45.1%. Of the 3115 men sampled, 57 had \"low English\" or equivalent recorded.

![Participant disposition.](1471-2458-7-126-1){#F1}

Non- responders
---------------

A comparison between non-responders and the 1195 study participants is shown in Table [2](#T2){ref-type="table"}. Non-responders were those men that refused participation in the study but had completed some or all of a series of supplementary demographic questions.

###### 

Selected characteristics of FAMAS participants & non-responders

  Characteristic                          Participant        Non-Responder      *p*-value
  --------------------------------------- ------------------ ------------------ ------------
  **Region:**                             **\[n = 1195\]**   **\[n = 1920\]**   **0.12**
  Western Adelaide                        589 (49.3)         1002 (52.2)        
  Northern Adelaide                       606 (50.7)         918 (47.8)         
                                                                                
  **Age Group:**                          **\[n = 1195\]**   **\[n = 487\]**    **0.40**
  35--44                                  271 (22.7)         125 (25.7)         
  45--54                                  326 (27.3)         136 (27.9)         
  55--64                                  305 (25.5)         108 (22.2)         
  65--80                                  293 (24.5)         118 (24.2)         
                                                                                
  **Height (cm): mean (sd)**              **\[n = 1195\]**   **\[n = 556\]**    **0.81**
                                          175.8 (7.2)        175.7 (7.4)        
  **Weight (kg): mean (sd)**              **\[n = 1194\]**   **\[n = 529\]**    **0.26**
                                          85.1 (14.7)        84.2 (15.7)        
  **BMI (kg/cm^2^): mean (sd)**           **\[n = 1194\]**   **\[n = 518\]**    **0.35**
                                          27.5 (4.4)         27.3 (4.6)         
  **BMI Category:**                       **\[n = 1194\]**   **\[n = 518\]**    **0.33**
  Underweight (\< 20)                     25 (2.1)           9 (1.7)            
  Normal (20--24.9)                       324 (27.1)         162 (31.3)         
  Overweight (25--30)                     556 (46.6)         234 (45.2)         
  Obese (\>30)                            289 (24.2)         113 (21.8)         
                                                                                
  **Current Smoker:**                     **\[n = 1195\]**   **\[n = 576\]**    **0.001**
  Yes                                     216 (18.1)         147 (25.5)\*       
  No                                      945 (79.1)         413 (71.7)         
  Occasionally                            34 (2.8)           16 (2.8)           
  **Ever Smoked Regularly:**              **\[n = 979\]**    **\[n = 429\]**    **0.83**
                                          556 (56.8)         241 (56.2)         
                                                                                
  **Ever High Cholesterol:**              **\[n = 1195\]**   **\[n = 572\]**    **0.03**
  Yes                                     447 (37.4)         181 (31.6)         
  No                                      714 (59.7)         381 (66.6)\*       
  Don\'t know                             15 (1.3)           6 (1.0)            
  Never Measured                          19 (1.6)           4 (0.7)            
  **Current High Cholesterol:**           **\[n = 438\]**    **\[n = 181\]**    **0.0003**
  Yes                                     236 (53.9)         99 (54.7)          
  No                                      70 (16.0)          50 (27.6)\*        
  Don\'t know                             132 (30.1)         32 (17.7)          
                                                                                
  **Ever High Blood Pressure:**           **\[n = 1195\]**   **\[n = 572\]**    **0.25**
  Yes                                     375 (31.4)         186 (32.5)         
  No                                      816 (68.3)         381 (66.6)         
  Don\'t know                             3 (0.3)            5 (0.9)            
  **Current High Blood Pressure:**        **\[n = 365\]**    **\[n = 186\]**    **0.41**
  Yes                                     265 (72.6)         142 (76.3)         
  No                                      77 (21.1)          37 (19.9)          
  Don\'t know                             23 (6.3)           7 (3.8)            
                                                                                
  **No. Adults (18+) in Household:**      **\[n = 1179\]**   **\[n = 576\]**    **0.03**
  1                                       169 (14.3)         109 (18.9)\*       
  2                                       788 (66.8)         357 (62.0)         
  3                                       144 (12.2)         81 (14.1)          
  4+                                      78 (6.6)           29 (5.0)           
  **No. Children (\<18) in Household:**   **\[n = 1179\]**   **\[n = 576\]**    **0.32**
  0                                       862 (73.1)         407 (70.7)         
  1                                       103 (8.7)          64 (11.1)          
  2                                       149 (12.6)         78 (13.5)          
  3                                       55 (4.7)           20 (3.5)           
  4+                                      10 (0.8)           7 (1.2)            
                                                                                
  **Physical Conditions**                                                       
  **Diabetes:**                           **\[n = 1195\]**   **\[n = 575\]**    **0.0003**
                                          106 (8.9)\*        84 (14.6)          
  **Asthma:**                             **\[n = 1195\]**   **\[n = 575\]**    **0.06**
                                          134 (11.2)         48 (8.3)           
  **Bronchitis:**                         **\[n = 1179\]**   **\[n = 575\]**    **0.12**
                                          142 (12.0)         55 (9.6)           
  **Emphysema:**                          **\[n = 1179\]**   **\[n = 575\]**    **0.94**
                                          30 (2.5)           15 (2.6)           
  **Heart Attack:**                       **\[n = 1179\]**   **\[n = 575\]**    **0.68**
                                          72 (6.1)           38 (6.6)           
  **Stroke:**                             **\[n = 1179\]**   **\[n = 575\]**    **0.04**
                                          21 (1.8)\*         19 (3.3)           
  **Angina:**                             **\[n = 1195\]**   **\[n = 575\]**    **0.77**
                                          62 (5.2)           28 (4.9)           
  **None of the above:**                  **\[n = 1179\]**   **\[n = 575\]**    **0.95**
                                          781 (66.2)         380 (66.1)         
                                                                                
  **Psychological Conditions**                                                  
  **Anxiety:**                            **\[n = 1195\]**   **\[n = 575\]**    **0.15**
                                          29 (5.0)           43 (3.6)           
  **Depression:**                         **\[n = 1195\]**   **\[n = 575\]**    **0.53**
                                          60 (5.0)           33 (5.7)           
  **Stress:**                             **\[n = 1179\]**   **\[n = 575\]**    **0.73**
                                          55 (4.7)           29 (5.0)           
  **Other:**                              **\[n = 1179\]**   **\[n = 575\]**    **0.82**
                                          11 (0.9)           6 (1.0)            
  **None of the above:**                  **\[n = 1179\]**   **\[n = 575\]**    **0.76**
                                          1065 (90.3)        522 (90.8)         

Participants were classified as those men that completed all CATI preliminary questions and attended baseline clinics; Non-responders were those men that refused participation in the study but had completed some or all of the preliminary questions. Data presented as *n*(%) unless stated. \* Denotes the category was statistically significant compared with non-responders based on standardised chi-squared cell residuals with magnitude \< or \>3.

There was no age difference observed between participants and non-responders. Similarly, there was no difference between groups for area of residence, estimated body mass index (BMI: calculated from self-reports of weight & height), or number of children in a household. Additionally, no obvious difference existed in the type of work men had done for most of their lives (data not shown).

In terms of health status, non-responders were no different in prevalence of physician-diagnosed incidences of hypertension, asthma, bronchitis, emphysema, heart attacks, episodes of angina or mental health conditions (anxiety, depression, stress or other). However, there was an increased prevalence of diabetes and stroke in those that chose not to participate. There was no recorded difference between groups for participants reporting an absence of existing health conditions. Non-responders were, however, more likely to live alone and be current smokers (although there was no difference between groups on whether they had previously smoked regularly). Non-responders were also less likely to report elevated cholesterol levels (both previously and at time of interview).

3.3 Loss to follow-up
---------------------

In order to assess the non-randomness of any loss to follow up (LTFU) for the study to date, a comparison of selected demographics (age, employment & marital status, education & income) between active FAMAS participants and study losses was performed (Table [3](#T3){ref-type="table"}). Subject losses (deaths, withdrawals) were more likely to occur in the elderly subset. No other differences in the selected demographics were observed. Of all study withdrawals, 39.5% were as a result of death. The most commonly cited causes for retraction of consent were \"increased time demands\" (27.3%) and \"lack of interest\" (13.1%). Allowing for deaths, withdrawals and non-contactable participants, the current annual loss rate for the study is only 1.1%.

###### 

Demographic characteristics of study withdrawals

  Demographic                          Active Participants   Withdrawn        *p*value
  ------------------------------------ --------------------- ---------------- ----------
  **Age Group**:                       **\[n = 1155\]**      **\[n = 40\]**   **0.04**
  35--44                               267 (23.1)            4 (10.0)         
  45--54                               318 (27.5)            8 (20.0)         
  55--64                               293 (25.4)            12 (30.0)        
  65--80                               277 (23.9)            16 (40.0)\*      
                                                                              
  **Marital Status**:                  **\[n = 1153\]**      **\[n = 40\]**   
  Married/Living With a Partner        940 (81.4)            34 (85.0)        
  Separated/Divorced                   124 (10.7)            2 (5.0)          
  Widowed                              32 (2.8)              1 (2.5)          
  Never Married                        57 (5.0)              3 (7.5)          
                                                                              
  **Employment Status**:               **\[n = 1155\]**      **\[n = 40\]**   
  Employed-full time                   587 (50.8)            10 (25.0)        
  Employed part-time                   109 (9.4)             2 (5.0)          
  Employed-self employed/not stated    61 (5.1)              6 (15.0)         
  Unemployed                           31 (2.7)              1 (2.5)          
  Not in work force                    367 (31.4)            21 (52.5)        
                                                                              
  **Education**:                                                              
  **Any Qualification Post School:**   **\[n = 1149\]**      **\[n = 39\]**   
  Yes                                  827 (71.6)            23 (57.5)        
  No                                   322 (27.9)            16 (40.0)        
  **Highest Qualification**:           **\[n = 822\]**       **\[n = 23\]**   
  Bachelor degree or higher            141 (17.0)            1 (4.2)          
  Trade/Apprenticeship                 378 (45.5)            14 (58.3)        
  Certificate/Diploma                  256 (30.8)            7 (29.2)         
  Other                                47 (5.7)              1 (4.2)          
                                                                              
  **Gross Annual Household Income**    **\[n = 1134\]**      **\[n = 40\]**   
  Up to \$12,000                       77 (6.7)              3 (7.5)          
  \$12,001 -- \$20,000                 151 (13.1)            13 (32.5)        
  \$20,001 -- \$30,000                 157 (13.6)            8 (20.0)         
  \$30,001 -- \$40,000                 131 (11.3)            2 (5.0)          
  \$40,001 -- \$50,000                 132 (11.4)            4 (10.0)         
  \$50,001 -- \$60,000                 142 (12.3)            3 (7.5)          
  \$60,001 -- \$80,000                 153 (13.3)            3 (7.5)          
  More than \$80,000                   191 (16.5)            4 (10.0)         

Study withdrawals were those participants lost to follow-up (withdrawn consent, death, lost contact) since first enrolment (Aug 2002). Data presented as *n*(%) unless stated. \* Denotes the category was statistically significant compared with active participants based on standardised chi-squared cell residuals with magnitude \< or \> 3.

3.4 Demographics of study participants
--------------------------------------

Demographic characteristics of FAMAS participants, and where appropriate, corresponding Census data are shown in Table [4](#T4){ref-type="table"}.

###### 

Demographic profile of FAMAS participants.

                                       FAMAS   Census -- NW Adel   Census -- Aus                      
  ------------------------------------ ------- ------------------- --------------- ------ ----------- ------
  **Age**                                                                                             
  35--44                               271     22.7\*              40,931          32.4   1,409,361   32.0
  45--54                               326     27.3                34,993          27.7   1,276,302   29.0
  55--64                               305     25.5\*              24,271          9.2    884,786     20.1
  65--80                               293     24.5                32,409          20.6   835,577     19.0
                                                                                                      
  **Region of Birth**                                                                                 
  Oceania                              806     67.4                188,475         70.7   6,939,747   74.9
  Australia                            795     66.5                186,324         69.9   6,712,876   72.4
  Other                                11      0.9                 2,151           0.8    226,871     2.4
  Europe                               345     28.9                49,510          18.6   1,077,073   11.6
  UK &Ireland                          218     18.2                26,230          9.8    545,146     5.9
  Other                                127     10.6                23,280          8.7    531,927     5.7
  Asia                                 29      2.4                 10,392          3.9    57,172      4.9
  Africa                               7       0.6                 2,410           0.9    183,236     2.0
  Americas                             6       0.5                 1,497           0.6    78,612      0.8
  Other                                0       0.0                 216             0.1    8,653       0.1
                                                                                                      
  **Marital Status**:                                                                                 
  Married or Living With a Partner     974     81.5                86,567          68.6   3,118,768   64.1
  Separated/Divorced                   126     10.5                19,891          15.8   623,689     16.6
  Widowed                              33      2.8                 3,607           2.9    116,676     3.2
  Never Married                        60      5.0\*               16,142          12.8   546,893     16.1
                                                                                                      
  **Employment Status**:                                                                              
  Employed-full time                   597     50.0                71,567          48.5   2,210,528   47.9
  Employed-part-time                   111     9.3                 13,681          9.3    477,007     10.3
  Employed-self employed/not stated    42      3.5                 1,795           1.2    77,849      1.7
  Unemployed                           32      2.7                 5,992           4.1    173,473     3.8
  Not in work force                    405     33.9                50,555          34.2   1,474,897   32.0
                                                                                                      
  **Education**:                                                                                      
  **Any qualification post-school?**                                                                  
  Yes                                  850     71.1                46,025          35.8   2,977,559   41.0
  No                                   338     28.3                71,721          55.7   3,532,760   48.6
  **Non-school qualification**:                                                                       
  Bachelor or higher                   142     24.2                7,643           13.4   910,318     24.4
  Trade                                392     66.8                38,382          67.4   2,067,241   55.4
  Other                                48      8.2                 10,907          19.2   752,225     20.2

Census data was obtained from the Australian Bureau of Statistics\' Basic Community Profiles for Australian, Northern Adelaide and Western Adelaide Statistical Divisions. Census data on employment status is available for all household males in the respective divisions aged 35 years or over. Census data on education includes all household males aged 15 years or over. \* Denotes the category was statistically significant compared with Census 2001 data using standardised chi-squared cell residuals with magnitude \< or \> 3.

### Age

Table [4](#T4){ref-type="table"} shows the age distribution of the cohort. The mean age of the study participants was 55.0 ± 11.6 (min. 35 -- max 80 at clinic). Residual analysis from a goodness-of-fit test demonstrated that young males (\<45) were under represented and 55--64 years old were over represented in comparison to Census data (data not shown).

### Marital status

Eighty-two percent (N = 974) of men were married or living with a partner. In comparison to Census data, there was an under representation of men who had never married (Table [4](#T4){ref-type="table"}).

### Region of birth

Sixty-seven percent (N = 795) of participants were born in Australia, slightly higher proportions than observed in both Census figures (Table [4](#T4){ref-type="table"}). The most frequent countries of birth outside of Australia were the United Kingdom (including North Ireland, Scotland and Wales) & Ireland with 218 participants (18.2%). Such participants appeared to be overrepresented in the study sample as compared to the broader population. Of the men born outside Australia, the average amount of time spent in Australia was 36.5 ± 11.9 years.

### Employment status

Fifty percent (N = 597) of participants were in full-time employment; 9% (N = 111) part-time and 4% (N = 42) self-employed, whilst 3% (N = 32) were unemployed at time of survey. Thirty-four percent (N = 405) had no active involvement with the work force, the majority of whom were retired (N = 351). In general, there was good agreement between study and Census figures of employment (Table [4](#T4){ref-type="table"}).

### Education level

Seventy-one percent (N = 848) of men had obtained some form of qualification since leaving school (Table [4](#T4){ref-type="table"}). Sixty-seven percent (N = 392) had obtained a trade qualification or equivalent, 24% (N = 142) had a bachelor degree or higher whilst 8% (N = 48) reported having some other qualification (Table [4](#T4){ref-type="table"}). The average age that participants left school was 16.0 ± 2.0 years old. When compared to Census figures, which include all males over the age of 15 years, the FAMAS cohort appears to display a higher proportion of study participants with some form of post-school qualification; specifically, a higher proportion of trade & tertiary qualifications were observed in the cohort when compared to North West Adelaide and Australian males, respectively (Table [4](#T4){ref-type="table"}).

### Gross annual household income

For an approximate comparison, Census income data (Average Weekly Earnings) were extrapolated into annual figures. Of the 98% of study participants who disclosed their gross annual household income, 7% (N = 80) of men had gross household incomes in the lowest bracket (up to \$12,000 p.a.) (Figure [2](#F2){ref-type="fig"}) which appeared to be a higher proportion than that observed in the target population. The remaining income brackets in the cohort were consistent with the distribution observed in the broader populations (Figure [2](#F2){ref-type="fig"}), with the noted exception of an absence of the high-income spike observed in the Australian data.

![**Comparison of annual incomes between Census 2001 data and FAMAS participants**. Available Census 2001 income figures (Average Weekly Family Income) were altered to approximate collected annual gross household data. End income brackets were multiplied by 52; reported family income data was assumed to reflect gross household income.](1471-2458-7-126-2){#F2}

Discussion
==========

The population sampled for the Florey Adelaide Male Ageing Study (FAMAS) has yielded participants broadly representative of the sampling region and the broader Australian population of Australian men aged 35--80 in key demographics. Efforts will now focus on maintaining participation in a unique and expanding investigative base.

All longitudinal studies must include an assessment of their baseline response rates \[[@B33]\]. Studies with low levels of initial recruitment can potentially introduce significant levels of selection bias into the sample. Response rates can be difficult to interpret as the methods used to calculate them are often not specified. Some studies report response rates as a percentage of eligible people in the sample, whilst others report it as a percentage of the entire sample. The former often leads to much higher rates. Our chosen method concurs with that most often used in research of this type \[[@B33]\]. By way of comparison, our observed response rates (sample: 67.8%; clinic: 45.1%) appear much higher than those of another study (clinic response rate: 29%) using very similar sampling procedures \[[@B34]\]. Certainly given the study type and investigations (including detailed sexual health measures), the observed response rates seem sufficient.

Several other studies have employed additional methods to bolster their recruitment rates (see \[[@B32]\] for review). These have included the use of \"volunteer enrichment\" (e.g. Framingham Heart Study, \[[@B35]\]), whereby investigators allowed unsolicited participants to enter the study. Whilst many approaches from suitable candidates were received during promotional activities for the study, such requests were declined in favour of maintaining a randomly-selected sample. We have, however, managed to achieve reasonable levels of initial recruitment from our target population by minimizing exclusion criteria and incorporating measures in our study design that would appeal to our target population. Indeed, most studies \[[@B36],[@B37]\] report that participation seems largely related to the perceived benefits of participation. Thus, measures such as a comprehensive health review and relatively low contact time appear to have helped increase involvement in a population traditionally hesitant to participate \[[@B38],[@B39]\]. Despite this, the most commonly cited reasons for study refusal were householders being either \'too busy\' or \'not interested\', universal responses in any study of this type \[[@B40]\]. Interestingly, people citing being \'too old\', \'too sick\' or for having \'no health problems\' were only minor contributors to study refusal, in contrast to previous findings \[[@B41],[@B42]\]. Whilst the reasons given for refusing participation in health research have been well documented elsewhere, there is a scarcity of such data from Australian male cohort studies. Such findings will have implications for future studies and preventative programmes involving ageing men.

Comparisons of non-responders and study participants in any study is useful in highlighting key points of difference between the two groups and allowing for an estimation of any sources of selection bias. The under representation of single men in the cohort provides further agreement with a volume of research \[[@B43]\] that suggests that people (especially the elderly) with live-in support systems generally demonstrate higher levels of attendance in health studies (and, more generally, better health outcomes) than people who live alone. There is also strong evidence to suggest that non-responders tend to display poorer health outcomes (e.g. an increased incidence of strokes \[[@B44]\] and diabetes \[[@B45]\]). However, in the present study non-participators were less likely to have had previous and current episodes of hypercholesterolemia. During pre-recruitment promotion, strong emphasis was placed on the free cholesterol testing and, combined with a recent national emphasis on elevated cholesterol levels, this may have dissuaded men who had previously or were currently receiving treatment. In all, our analyses do suggest that our study participants are broadly representative of the sampled population and that those that were unwilling to participate did not create a substantial bias. However, the observed discrepancies will have to be taken into account when applying study results to the overall population.

In any longitudinal design, particular effort is needed in characterizing loss to follow up (LTFU) in order to help identify potential sources of future cohort loss \[[@B46]\]. Previous research has identified a host of demographic factors that are associated with LTFU (see \[[@B31]\] for review). In most population studies, those greater than 60 years are less likely to withdraw \[[@B47]\], although this is likely offset by an elevated death rate. Indeed, in the present study, almost half of all study losses were as a result of participant death, the large majority of which came from the initial 65--80 age bracket. Aside from age, no other demographic factor appears to have influenced LTFU. The current LTFU rates are extremely low in comparison to other studies of this type \[[@B4]\]. Whilst it is acknowledged that our second wave of clinic visits is yet to begin, we have none the less been able to maintain a good rate of contact with most of the cohort to date through a host of activities. Although efforts to maximize participation appear to have been effective, other successful measures adopted by similar studies (especially in the critical elder and younger brackets \[[@B47]-[@B49]\]) will also be utilized to maintain the stability of the cohort.

Whilst the ability to generalize results from a given study to the broader population is one of the key elements of longitudinal research it is quite often not the primary focus of the study. Certainly many of the more noted cohort studies (e.g. British Doctors Survey \[[@B50]\], CARDIA \[[@B51]\], Framingham \[[@B52]\]) were non-representative by design. In the present study however a broadly representative cohort was sought. As argued by Szklo \[[@B33]\], an important determinant in realizing a representative cohort is the selection of a complete sampling frame. In this context, our use of the Electronic White Pages may be seen as a limitation given that this restricts potential respondents to those with a connected line. However, research \[[@B14],[@B53]\] using a comparable sampling technique, has suggested that this is not the case.

In terms of the age profile of our cohort, the lower proportion of young males in the cohort is notable. This is a common phenomenon in studies with similar sampling designs \[[@B31],[@B53]\] and a number of initiatives to maximize the ongoing involvement of this group of men have been adopted in consequence (e.g. family days, targeting specific media outlets). The overrepresentation of the elderly has also been observed previously, and whilst the reasons for this are situation-dependant, it is generally considered that such participants can offer more time to community-based research \[[@B54]\]. Whilst the profile of FAMAS participants did significantly differ from the broader community in selected age groups, the careful application of appropriate weights to future results should offset any age-influenced bias. Additionally, the present age profile will help to ensure adequate inter-age group comparisons can be performed, an important consideration in any ageing longitudinal study. Indeed, we would argue that our cohort is well placed long-term to cope with the attrition normally associated with studies of this type.

The low numbers in some regions of birth means that a statistical comparison was not warranted. Most notably, we do appear slightly overrepresented with participants from the UK/Ireland. Whilst no clear reasons exist for this discrepancy, it is interesting to note that some of the highest response rates for population studies are recorded in British surveys \[[@B55]\]. The apparent lower proportions in other regions (whilst not statistical) are slightly more difficult to explain, and may reflect a general trend towards non-participation in this country \[[@B56]\]. Similar patterns have been observed in a nationwide telephone-based survey of the reproductive health of approximately 6000 men age 40--80 (Men in Australia: Telephone Survey; MATeS) \[[@B57],[@B58]\].

The income distribution for the cohort also appears broadly reflective of the wider populations. The disparity between the proportion of high household incomes in the north west Adelaide and Australian populations is indicative of some of the socio-economic disadvantages of the region \[[@B59]\].

Many population studies report that a respondents level of education strongly predicts their likelihood of involvement \[[@B60],[@B61]\]. This notion received support in the present study with a higher proportion of participants with some post-school qualification as compared to the general population. These figures bode well for the stability of the cohort, with previous research demonstrating that those with a higher educational standard are less likely to withdraw \[[@B62],[@B63]\]. Taken together, these figures suggest that the men in the present study are generally reflective of the community from which they were randomly selected and the Australian population as a whole.

In terms of the overall study frame, the occurrence of clinics at every five years should be adequate for the conditions under investigations. Whilst other cohort studies have benefited from more frequent clinical investigations \[[@B62],[@B63]\] these studies were investigating inherently dynamic disease conditions or outcomes. In addition to the logistical and financial expense associated with clinics, participant contact beyond that which is necessary is likely to lower recruitment and increase LTFU. Also, in the present study there is a sustained effort to keep regular contact with participants in between clinic waves through annual follow-up questionnaires, sub-study investigations and cohort maintenance initiatives. In comparison to other longitudinal studies of ageing the incorporation of a \"younger\" subset is quite unique \[[@B4]\] and, provided these numbers can be maintained, will provide an invaluable opportunity to study the progression of various conditions and changing behaviours in men.

An *a priori*target of around 1200 participants was selected before recruitment ensuring sufficient power for the main outcome variables. Even relatively minor correlations between outcomes could be reliably detected. Whilst this cohort size may be smaller in comparison to other longitudinal studies of ageing we would argue that the focus on a single gender and the high stability of the cohort observed to date (in part due to the conscious efforts to minimize losses to follow-up) will ensure a relatively large number of active, participating subjects for the duration of the study.

The north west region of Adelaide appears an ideal community in which to investigate the ageing process, with a population that is largely reflective of the state with the highest proportion of elderly in Australia. The urban-specific focus of the study may limit the broader applicability of study results, however in the present circumstance incorporating regional participants was not feasible. Also, at present there are no home visits planned for participants with limited mobility given the logistics and expenses involved. There is still considerable debate on whether such measures can reduce the high attrition associated with elderly participants in cohort studies \[[@B64]\].

Conclusion
==========

The Florey Adelaide Male Ageing Study will provide an opportunity to add to existing ageing longitudinal research, both internationally and locally, with a well-characterized, broadly representative cohort that remains largely active. The study design reflects a growing trend of integrative research on ageing with inputs from a range of disciplines (endocrinology, epidemiology, gerontology, public health, psychology, sociology, ophthalmology, bone and joint disease, nutrition, genomic health, politics). The inclusion of middle aged participants is unique relative to most ageing longitudinal studies, and will allow the detection of earlier life trajectories and morbidity factors associated with healthy ageing in later life. Of the few longitudinal studies specific to conditions affecting men in Australia, most are characterised as specialized investigations of the late elderly, limiting the scope of problems addressed and the potential as a longitudinal study. By contrast, FAMAS offers a broad-based approach to many of the conditions of the ageing male, increasing acknowledged as areas that require significant research input.
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